Baylor, GE Medical Launch ‘The Health Channel’

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

HOUSTON-GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

HOUSTON—GE Medical Systems and Baylor College of Medicine have launched a 24-hour satellite programming service to deliver accredited, continuing education for physicians, nurses, and other allied health professionals directly to hospitals.

The new service, called The Health Channel, is directed by Baylor College of Medicine and Texas Children’s Hospital, and is available through GE Medical Systems’ TiP-TV satellite broadcast network. Currently, 1,600 health care facilities in the US, Canada, and Europe provide TiP-TV programming to their staff.

Programs are developed and accredited by Baylor in cooperation with a consortium of leading academic medical institutions, including The Cleveland Clinic Foundation, Duke University Medical Center, the Mayo Clinic, M.D. Anderson Cancer Center, and others.

Programs repeat frequently to accommodate various day and night staff schedules. The channel runs 24 hours a day, 7 days a week, with new programming offered every week. A bi-monthly broadcast guide lists dates and times.

The monthly subscription rate for The Health Channel varies depending on hospital bed size and can range from $750 to $3,000. Hospitals can subscribe by calling toll free 1-877-GE TiPTV (1-877-438-4788). More information on the new service is available at the Channel’s website, www.healthchannelweb.com.

Recent Videos
Surgery and radiation chemotherapy can affect immunotherapy’s ability to target tumor cells in the nervous system, according to John Henson, MD.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
Related Content